申请人:Das Jagabandhu
公开号:US20130190361A1
公开(公告)日:2013-07-25
Disclosed are compounds of Formula (I):
or stereoisomers, N-oxides, salts, or prodrugs thereof; wherein: Ring A is phenyl or 5- to 6-membered heteroaryl; (i) R1 and R2 are independently C1-C4 alkyl; or (ii) R1 and R2 together with the carbon atom to which they are attached, form a cyclic group; Q is phenyl or 5- to 6-membered heteroaryl substituted with zero to 3 substituents; and R3, L1, L2, and n are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
本发明涉及以下式(I)的化合物或其立体异构体、N-氧化物、盐或前药:
其中:环A是苯基或5-至6-成员杂环基;
(i) R1和R2独立地是C1-C4烷基;或
(ii)R1和R2与它们连接的碳原子一起形成一个环状基团;
Q是苯基或5-至6-成员杂环基,其被0-3个取代基取代;R3、L1、L2和n的定义详见说明书。
本发明还涉及将这些化合物用作选择性G蛋白偶联受体S1P1的激动剂的方法,以及包含这些化合物的制药组合物。这些化合物在多种治疗领域中用于治疗、预防或减缓疾病或障碍的进展,如自身免疫性疾病和血管疾病。